Tefron Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
For the nine months, sales was USD 159.67 million compared to USD 197.83 million a year ago. Net income was USD 5.36 million compared to USD 11.85 million a year ago. Basic earnings per share from continuing operations was USD 0.44 compared to USD 1 a year ago. Diluted earnings per share from continuing operations was USD 0.41 compared to USD 0.92 a year ago.